TBL1XR1 and breast carcinoma: Furthermore, we have demonstrated that TBLR1 may promote proliferation and tumorigenicity in breast cancer cells via activation of the β-catenin signaling pathway, which provides a novel molecular mechanism for breast cancer progression.